Search
for
Sort by
Research 421–450 of 1000+
- Progress in Topical and Transdermal Drug Delivery Research—Focus on Nanoformulations
- Decrypting the Potential of Nanotechnology-Based Approaches as Cutting-Edge for Management of Hyperpigmentation Disorder
- Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)
- Recent advances in understanding the role of the skin microbiome in the treatment of atopic dermatitis
- Can we teach old drugs new tricks?—Repurposing of neuropharmacological drugs for inflammatory skin diseases
- Serum level of vitamin D in patients with alopecia areata
- The protease corin regulates electrolyte homeostasis in eccrine sweat glands
- Synthetically programmed antioxidant delivery by a domesticated skin commensal
- Evaluation of Serum Inflammatory Markers and Their Relationship to Treatment Response in Alopecia Areata Patients
- Alopecia Areata Occurring after COVID-19 Vaccination: A Single-Center, Cross-Sectional Study
- Pathophysiology of Alopecia Areata in the Pediatric Patient
- II Consensus of the Brazilian Society of Dermatology for the treatment of alopecia areata
- Dietary Habits in Japanese Patients with Alopecia Areata
- How Our Microbiome Influences the Pathogenesis of Alopecia Areata
- Intracellular protons accelerate aging and switch on aging hallmarks in mice
- Subclinical Atherosclerosis in Alopecia Areata: Usefulness of Arterial Ultrasound for Disease Diagnosis and Analysis of Its Relationship with Cardiometabolic Parameters
- 67 Patterns of clinical response in patients with alopecia areata (AA) treated with ritlecitinib in the ALLEGRO phase 2b/3 and ongoing, phase 3, ALLEGRO-LT studies
- Hypertension's 3 Dilemmas and 3 Solutions: Pharmacology of the Kidney in Hypertension
- Effective treatment of refractory alopecia areata in pediatric patients with oral abrocitinib
- Evaluation of the serum C‐reactive protein–albumin ratio and its relationship with disease severity IN alopecia areata: A prospective case–control study
- AIRE Deficiency Leads to the Development of Alopecia Areata‒Like Lesions in Mice
- Not just thinning: A case of alopecia universalis after mild COVID-19
- Genomic and Transcriptomic Characterization of Atypical Recurrent Flank Alopecia in the Cesky Fousek
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase 1/2 inhibitor, in adults with alopecia areata: Results from the THRIVE-AA2 Phase 3, randomized, double-blind, controlled trial
- Efficacy of Upadacitinib in Treating Alopecia Areata, Atopic Dermatitis, and Th1 Comorbidities in Pediatric Patients: A Comprehensive Case Series and Literature Review
- Efficacy of Baricitinib in Patients with Various Degrees of Alopecia Areata Severity: Post-Hoc Analysis from BRAVE AA1 and BRAVE AA2
- Efficacy of Acupuncture Therapy in a Patient with Long-Standing Alopecia Areata: A Case Report
- Progress in the Expression, Purification, and Characterization of Recombinant Collagen
- Comprehensive Review on Hair Loss and Restorative Techniques: Advances in Diagnostic, Artistry, and Surgical Innovation
- Myo-Inositol (ProFecund Ino) – Obtaining a Pregnancy in Women with Polycystic Ovary Syndrome